Lv1
34 积分 2022-03-14 加入
Lenvatinib combined with PD-1 inhibitor plus Gemox chemotherapy versus plus HAIC for advanced biliary tract cancer
3天前
已完结
BRAF V600E mutation and MET amplification as resistance pathways of the second-generation anaplastic lymphoma kinase (ALK) inhibitor alectinib in lung cancer
17天前
已完结
Alectinib relieves ischemic strokes caused by left atrial metastasis in a NSCLC patient with a novel SLC34A2-ALK (exon 1: exon 15) fusion
17天前
已完结
Tumor-Agnostic Genomic and Clinical Analysis of BRAF Fusions Identifies Actionable Targets
1个月前
已完结
Non-small-cell lung cancer
1个月前
已完结
Inhibition of neuroactive ligand–receptor interaction pathway can enhance immunotherapy response in colon cancer: an in silico study
1个月前
已完结
Development and validation of a novel model to predict recurrence-free survival and melanoma-specific survival after sentinel lymph node biopsy in patients with melanoma: an international, retrospective, multicentre analysis
4个月前
已完结
POT1 mutations cause telomere dysfunction in chronic lymphocytic leukemia
5个月前
已完结
Prospective Evaluation of Circulating Tumor DNA using Next Generation Sequencing as a Biomarker during Neoadjuvant Chemotherapy in Localized Pancreatic Cancer
5个月前
已完结
Liquid biopsy in pancreatic cancer – Current perspective and future outlook
6个月前
已完结
皖公网安备34019202002308
